{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:46:00Z","timestamp":1791445560718,"version":"4.3.3"},"reference-count":49,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2024,10,8]]},"abstract":"<jats:p>Background: Older adults with dementia who are on polypharmacy are more vulnerable to the use of potentially inappropriate medications (PIM), which can significantly increase the risk of adverse events and drug-related problems (DRPs). Objective: This systematic review and meta-analysis were conducted to map the prevalence of PIM use, polypharmacy, and hyper-polypharmacy among older adults with cognitive impairment or dementia attending memory clinics. Methods: Ovid MEDLINE, Ovid EMBASE, Scopus, Cochrane Library, EBSCOhost CINAHL, and Ovid International Pharmaceutical Abstracts (IPA) were systematically searched from inception to April 22, 2024. Observational studies assessing the PIMs use among older adults with CI or dementia were screened. A random- effects meta-analysis was conducted to pool the prevalence estimates. Results: Of 5,787 identified citations, 11 studies including 4,571 participants from 8 countries were included. Among all the included studies the pooled prevalence of PIM use was 38% (95% confidence interval (CIn): 27\u2013 50%), highlighting a notable range from 20% to 78%. The analysis identified anticholinergics, benzodiazepines, and non-benzodiazepine sedatives as the most common PIMs. Subgroup analysis revealed a higher pooled prevalence of PIM in the USA (39%; 95% CIn: 10\u2013 78, I2 (%)\u200a=\u200a98, 3 studies) and Australia (36%, 95% CIn: 12\u2013 70, I2 (%)\u200a=\u200a96, 2 Studies). Additionally, pooled prevalence of polypharmacy and hyper-polypharmacy was reported as (60%; 95% CIn: 46\u2013 73, I2 (%)\u200a=\u200a95, 3 studies), and (The prevalence of hyper-polypharmacy was 17.6%; 1 study) respectively. Conclusions: The definition of PIMs significantly impacts study results, often more than geographical variations. The variability in criteria and tools like the Beers or Screening Tool of Older Persons\u2019 Prescriptions (STOPP) criteria across studies and regions leads to differing prevalence rates.<\/jats:p>","DOI":"10.3233\/jad-240575","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T13:11:30Z","timestamp":1728393090000},"page":"1107-1120","source":"Crossref","is-referenced-by-count":18,"title":["Prevalence of Potentially Inappropriate Medications in Older Adults with Cognitive Impairment or Dementia Attending Memory Clinics: A Systematic Review and Meta-Analysis"],"prefix":"10.1177","volume":"101","author":[{"given":"Rishabh","family":"Sharma","sequence":"first","affiliation":[{"name":"School of Pharmacy, University of Waterloo, Kitchener, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasdeep Kaur","family":"Gill","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Waterloo, Kitchener, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manik","family":"Chhabra","sequence":"additional","affiliation":[{"name":"Indo-Soviet Friendship College of Pharmacy, Ghall Kalan, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Carter","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Waterloo, Kitchener, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajd","family":"Alkabbani","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Waterloo, Kitchener, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Vidyasagar","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University College of Pharmaceutical Sciences, Kakatiya University, Warangal, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Waterloo, Kitchener, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Lee","sequence":"additional","affiliation":[{"name":"Schlegel-UW Research Institute for Aging, Waterloo, Ontario, Canada"},{"name":"CFFM MINT Memory Clinic, Kitchener, Ontario, Canada"},{"name":"Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejal","family":"Patel","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Waterloo, Kitchener, Ontario, Canada"},{"name":"Schlegel-UW Research Institute for Aging, Waterloo, Ontario, Canada"},{"name":"CFFM MINT Memory Clinic, Kitchener, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-240575_ref1","first-page":"249","volume-title":"Future directions for the demography of aging: Proceedings of a workshop","author":"Langa","year":"2018"},{"key":"10.3233\/JAD-240575_ref2","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/alz.12362","article-title":"Population estimate of people with clinical AD and mild cognitive impairment in the United States (2020-2060)","volume":"17","author":"Rajan","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-240575_ref5","doi-asserted-by":"crossref","first-page":"e063891","DOI":"10.1136\/bmjopen-2022-063891","article-title":"Trends in prevalence and incidence of registered dementia and trends in multimorbidity among patients with dementia in general practice in Flanders, Belgium, 2000\u20132021: a registry-based, retrospective, longitudinal cohort study","volume":"12","author":"Beerten","year":"2022","journal-title":"BMJ Open"},{"key":"10.3233\/JAD-240575_ref6","doi-asserted-by":"crossref","first-page":"937486","DOI":"10.3389\/fnagi.2022.937486","article-title":"Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132019","volume":"14","author":"Li","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-240575_ref7","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3233\/JAD-191092","article-title":"The prevalence of dementia: a systematic review and meta-analysis","volume":"73","author":"Cao","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-240575_ref8","first-page":"33","article-title":"Comorbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data","volume":"46","author":"Clague","year":"2017","journal-title":"Age Ageing"},{"key":"10.3233\/JAD-240575_ref9","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/jgs.17291","article-title":"Polypharmacy among older adults with dementia compared with those without dementia in the United States","volume":"69","author":"Growdon","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-240575_ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-244X-14-84","article-title":"Comorbidity of dementia: a cross-sectional study of primary care older patients","volume":"14","author":"Poblador-Plou","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.3233\/JAD-240575_ref11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/WAD.0b013e31819d6ec9","article-title":"Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia","volume":"24","author":"Lau","year":"2010","journal-title":"Alzheimer Assoc Disord"},{"key":"10.3233\/JAD-240575_ref12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1715163517701770","article-title":"Use of potentially inappropriate medications among ambulatory home-dwelling elderly patients with dementia: a review of the literature","volume":"150","author":"Patel","year":"2017","journal-title":"Can Pharm J"},{"key":"10.3233\/JAD-240575_ref13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/2042098616670798","article-title":"Polypharmacy and inappropriate medication use in patients with dementia: an under researched problem","volume":"8","author":"Parsons","year":"2017","journal-title":"Ther Adv Drug Saf"},{"key":"10.3233\/JAD-240575_ref14","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society updated AGS Beers Criteria\u00a0\u00ae for potentially inappropriate medication use in older adults","volume":"71","author":"By the 2023 American Geriatrics Society Beers Criteria\u00a0\u00ae Update Expert Panel","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-240575_ref15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s11096-022-01380-0","article-title":"Comparison of the prevalence and nature of potentially inappropriate medication use in geriatric outpatients between tertiary and community healthcare settings: a multicenter cross-sectional study","volume":"44","author":"Zeng","year":"2022","journal-title":"Int J Clin Pharm"},{"key":"10.3233\/JAD-240575_ref16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3","volume":"14","author":"O\u2019Mahony","year":"2023","journal-title":"Eur Geriatr Med"},{"key":"10.3233\/JAD-240575_ref17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s40266-013-0118-4","article-title":"The medication appropriateness index at 20: where it started, where it has been, and where it may be going","volume":"30","author":"Hanlon","year":"2013","journal-title":"Drugs Aging"},{"key":"10.3233\/JAD-240575_ref18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mppsy.2007.12.001","article-title":"Memory clinics","volume":"7","author":"Kelly","year":"2008","journal-title":"Psychiatry"},{"key":"10.3233\/JAD-240575_ref19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/13607863.2010.543666","article-title":"Memory services and memory clinics","volume":"15","author":"Verhey","year":"2011","journal-title":"Aging Ment Health"},{"key":"10.3233\/JAD-240575_ref20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1177\/1060028014526857","article-title":"An interdisciplinary memory clinic: a novel practice setting for pharmacists in primary care","volume":"48","author":"Rojas-Fernandez","year":"2014","journal-title":"Ann Pharmacother"},{"key":"10.3233\/JAD-240575_ref21","first-page":"2023","article-title":"Medication Review in Cognitive Impairment and Dementia: Comparison of Instruments","author":"Sharma","journal-title":"Master\u2019s thesis, University of Waterloo"},{"key":"10.3233\/JAD-240575_ref22","first-page":"2020","article-title":"Assessing medication appropriateness in older adults and recommending therapeutic alternatives in individuals with dementia","author":"Bala","journal-title":"Doctoral dissertation, University of Otago"},{"key":"10.3233\/JAD-240575_ref23","doi-asserted-by":"crossref","first-page":"105100","DOI":"10.1016\/j.archger.2023.105100","article-title":"Medication overload: A closer look at polypharmacy and potentially inappropriate medications among older people in Taiwan and Japan","volume":"115","author":"Meng","year":"2023","journal-title":"Arch Gerontol Geriatr"},{"key":"10.3233\/JAD-240575_ref24","first-page":"2015","article-title":"Optimising prescribing in frail older people","author":"Poudel","journal-title":"PhD Thesis, School of Pharmacy, The University of Queensland"},{"key":"10.3233\/JAD-240575_ref25","first-page":"86","article-title":"Systematic reviews and meta-analyses: an illustrated, step-by-step guide","volume":"17","author":"Pai","year":"2004","journal-title":"Natl Med J India"},{"key":"10.3233\/JAD-240575_ref26","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int Surg J"},{"key":"10.3233\/JAD-240575_ref27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/emermed-2020-209567","article-title":"Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews","volume":"37","author":"Amir-Behghadami","year":"2020","journal-title":"Emerg Med J"},{"key":"10.3233\/JAD-240575_ref28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000539074","article-title":"Use of potentially inappropriate medications among older adults with dementia or cognitive impairment attending memory clinics: a protocol for a systematic review and meta-analysis","volume":"9","author":"Sharma","year":"2024","journal-title":"Biomed Hub"},{"key":"10.3233\/JAD-240575_ref29","unstructured":"Ga W . The Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. (accessed 10 June 2024)."},{"key":"10.3233\/JAD-240575_ref30","first-page":"2014","volume-title":"Systematic evidence reviews and clinical practice guidelines","author":"National Institutes of Health"},{"key":"10.3233\/JAD-240575_ref31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.3233\/JAD-240575_ref32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.3233\/JAD-240575_ref33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40266-015-0332-3","article-title":"Potentially inappropriate medications and anticholinergic burden in older people attending memory clinics in Australia","volume":"33","author":"Cross","year":"2016","journal-title":"Drugs Aging"},{"key":"10.3233\/JAD-240575_ref34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JAD-170265","article-title":"Potentially inappropriate medication, anticholinergic burden, and mortality in people attending memory clinics","volume":"60","author":"Cross","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-240575_ref35","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.sapharm.2020.01.010","article-title":"Deprescribing potentially inappropriate medications in memory clinic patients (DePIMM): a feasibility study","volume":"16","author":"Cross","year":"2020","journal-title":"Res Social Adm Pharm"},{"key":"10.3233\/JAD-240575_ref36","first-page":"1","article-title":"Identifying potentially inappropriate medications in memory clinic attendees. Abstracts of the 18th Congress of the European Geriatric Medicine Society","volume":"13","author":"Bromby","year":"2022","journal-title":"Eur Geriatr Med"},{"key":"10.3233\/JAD-240575_ref37","first-page":"218","article-title":"Polypharmacy and use of potentially inappropriate medications in patients with dementia and mild cognitive impairment","volume":"7","author":"Dhikav","year":"2014","journal-title":"Asian J Pharm Clin Res"},{"key":"10.3233\/JAD-240575_ref38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.amjopharm.2008.08.002","article-title":"Contraindicated medication use among patients in a memory disorders clinic","volume":"6","author":"Barton","year":"2008","journal-title":"Am J Geriatr Pharmacother"},{"issue":"Suppl 1","key":"10.3233\/JAD-240575_ref39","first-page":"S7","article-title":"Association between potentially inappropriate medication and mild cognitive impairment in patients attending memory clinics, Memento cohort","volume":"8","author":"Mouchoux","year":"2017","journal-title":"Eur Geriatr Med"},{"key":"10.3233\/JAD-240575_ref40","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00228-022-03410-2","article-title":"Potentially inappropriate medication use and mortality in patients with cognitive impairment","volume":"78","author":"Buckley","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"key":"10.3233\/JAD-240575_ref41","doi-asserted-by":"crossref","first-page":"ii9","DOI":"10.1093\/ageing\/afab219.57","article-title":"Potentially inappropriate medication use and mortality in patients with cognitive impairment","volume":"50","author":"Buckley","year":"2021","journal-title":"Age Ageing"},{"issue":"Suppl 3","key":"10.3233\/JAD-240575_ref42","first-page":"iii16","article-title":"Potentially inappropriate medication (PIMs) use and anticholinergic burden in memory clinic referrals in an Irish setting","volume":"46","author":"McCabe","year":"2017","journal-title":"Age Aging"},{"key":"10.3233\/JAD-240575_ref43","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3233\/JAD-190284","article-title":"Potentially inappropriate medications and polypharmacy: a study of older people with mild cognitive impairment and mild dementia","volume":"71","author":"Bonfiglio","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-240575_ref44","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4140\/TCP.n.2021.508","article-title":"Implementation of pharmacist reviews to screen for potentially inappropriate medications in patients with cognitive impairment","volume":"36","author":"Pearson","year":"2021","journal-title":"Sr Care Pharm"},{"key":"10.3233\/JAD-240575_ref45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2147\/CIA.S109125","article-title":"Drug prescription appropriateness in the elderly: an Italian study","author":"Allegri","year":"2017","journal-title":"Clin Interv Aging"},{"key":"10.3233\/JAD-240575_ref46","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jac5.1744","article-title":"Impact of medication optimization and recommendations by clinical pharmacists embedded in a memory disorder clinic","volume":"6","author":"Coli","year":"2023","journal-title":"J Am Coll Clin Pharm"},{"key":"10.3233\/JAD-240575_ref47","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00228-018-02612-x","article-title":"Identifying potentially inappropriate prescribing in older people with dementia: a systematic review","volume":"75","author":"Hukins","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"10.3233\/JAD-240575_ref48","doi-asserted-by":"crossref","first-page":"e2326910","DOI":"10.1001\/jamanetworkopen.2023.26910","article-title":"Prevalence of use of potentially inappropriate medications among older adults worldwide: a systematic review and meta-analysis","volume":"6","author":"Tian","year":"2023","journal-title":"JAMA Network open"},{"key":"10.3233\/JAD-240575_ref49","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/MLR.0000000000001221","article-title":"Response to propoxyphene market withdrawal: analgesic substitutes, doses, and adverse events","volume":"58","author":"Jeffery","year":"2020","journal-title":"Med Care"},{"key":"10.3233\/JAD-240575_ref50","doi-asserted-by":"crossref","first-page":"1265463","DOI":"10.3389\/fphar.2023.1265463","article-title":"Evaluation of potentially inappropriate medications for the elderly according to beers, STOPP, START, and Chinese criteria","volume":"14","author":"Zhu","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.3233\/JAD-240575_ref51","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3233\/JAD-170842","article-title":"Prevalence of potentially inappropriate medication use in older inpatients with and without cognitive impairment: a systematic review","volume":"61","author":"Redston","year":"2018","journal-title":"J Alzheimers Dis"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-240575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:59:10Z","timestamp":1777370350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/JAD-240575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":49,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-240575","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]}}}